Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 653-660
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.653
Table 2 Cox proportional hazard regression for overall survival and disease-free survival
VariablesβHR (95%CI)P value
Overall survival
Treatment (LRFA)0.8122.252 (0.983-5.156)NS
Sex (Male)0.0731.076 (0.426-2.717)NS
Age0.0081.008 (0.961-1.059)NS
Diagnosis (HCV)0.8282.288 (0.624-8.382)NS
Preop TACE (Yes)0.5001.649 (0.737-3.689)NS
No. intraop. nodules0.8002.225 (1.594-3.108)< 0.001
Local recurrence (Yes)-0.0140.985 (0.414-2.345)NS
Dist. recurrence (Yes)1.5434.680 (0.618-35.440)NS
Disease-free survival
Treatment (LRFA)0.4641.590 (0.771-3.282)NS
Sex (Male)0.5871.798 (0.732-4.422)NS
Age-0.0190.980 (0.939-1.024)NS
Diagnosis (HCV)-0.3000.740 (0.275-1.993)NS
Preop TACE (Yes)0.1251.133 (0.549-2.340)NS
No. intraop. nodules0.2161.241 (0.946-1.628)NS